Adragos Pharma is pleased to confirm its participation in the 14th Antibody Industrial Symposium (AIS2026), taking place in Montpellier, France. Organised by MabDesign and MabImprove, AIS2026 brings together leading players across the antibody and biologics value chain — from discovery through to commercial manufacturing. As a European Contract Development and Manufacturing Organisation (CDMO) with dedicated aseptic fill-and-finish capabilities for biological products, we look forward to connecting with biotech innovators, pharmaceutical companies, and industry partners at this year’s symposium.
Biologics Capabilities Built for the Antibody Industry
The antibody landscape demands manufacturing partners who understand the complexity of biologic drug products — from formulation development and clinical supply through to commercial-scale production. Adragos Pharma offers a strong European footprint with GMP-certified facilities purpose-built for sterile and aseptic manufacturing:
✔ Aseptic fill-and-finish for biologics and small molecules — liquid and lyophilised vials for clinical trial and commercial supply (Jura, Switzerland)
✔ Prefilled syringes, liquid and lyophilised vials — advanced aseptic filling, freeze-drying, and inspection systems (Maisons-Alfort, France)
✔ End-to-end CDMO services — from drug development and tech transfer to lifecycle management and commercial manufacturing
✔ Regulatory-ready, scalable processes — designed for the quality and compliance standards the biologics sector requires
Why Partner with Adragos Pharma for Antibody Manufacturing?
At Adragos Pharma, we combine multinational operational strength with personalised service. Our 7 GMP facilities across the EU, US, and Japan allow us to offer local insights and tailored solutions — because we know that one size does not fit all. From early-stage clinical supply through to full-scale commercial production, we invest in the success of your product beyond standard timelines.
Our established presence in Japan — the world’s most demanding pharmaceutical market — reflects our commitment to quality, adaptability, and long-term partnership.
Meet Our Team
Nancy Martinez
Senior Business Development Manager
Nancy brings a strong scientific background in biologics, CDMO services, and clinical project management to every conversation. With previous key roles at GTP Bioways and Pierre Fabre, she has supported innovative biotech and pharma projects across Europe. Her expertise spans antibody development, aseptic fill & finish, client relationship management, and strategic sales — offering a unique combination of technical insight and commercial acumen to partners in the life sciences industry.
About the 14th Antibody Industrial Symposium (AIS2026)
The Antibody Industrial Symposium, organised by MabDesign and MabImprove, is one of the premier European events dedicated to the antibody and therapeutic protein industry. AIS2026 brings together researchers, CDMOs, biotech companies, and pharmaceutical leaders for scientific presentations, partnering sessions, and networking — all focused on advancing the antibody sector from discovery to patient.
Connect with Us in Montpellier
Our team will be attending AIS2026 in Montpellier, and we welcome the opportunity to discuss your biologics manufacturing needs, explore potential collaborations, and share how Adragos Pharma can support your antibody pipeline — from clinical-stage fill-and-finish through to commercial supply.
📅 June 30- July 1st
📍 Montpellier, France
We look forward to meeting you and exploring new opportunities to advance antibody development and manufacturing together.
